Overview

Financials

News Ideas Discussions Technicals Seasonals

NAOV fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

‪3.16 M‬USD

—

−1.23USD

2003

Brian M. Murphy

nanovibronix.com

About

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

Ownership

‪‪8.72 M‬‬

Free Float shares

‪‪8.70 M‬‬ (99.79%)

Closely held shares

‪‪18.30 K‬‬ (0.21%)

Free Float shares

‪‪8.70 M‬‬ (99.79%)

Closely held shares

‪‪18.30 K‬‬ (0.21%)

Capital structure

Market cap

‪‪3.16 M‬‬

Debt

‪‪126.00 K‬‬

Cash & equivalents

‪‪1.30 M‬‬

Enterprise value

‪‪1.98 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary

‪‪3.16 M‬‬

Price to earning ratio (P/E)

—

Price to sales ratio (P/S)

0.30x

Market Cap

Net income

Revenue

Price to earning ratio (P/E)

—

Price to sales ratio (P/S)

0.30x

Valuation ratios

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

‪0.30‬

‪0.60‬

‪0.90‬

‪1.20‬

P/S

Growth and Profitability

Company’s recent performance and margins

Performance

‪−300%‬

‪−240%‬

‪−180%‬

‪−120%‬

‪−60%‬

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−1.20 M‬‬

‪‪−600.00 K‬‬

‪0.00‬

‪‪600.00 K‬‬

‪‪1.20 M‬‬

Revenue

Net income

Net margin %

Revenue to profit conversion

Revenue

COGS

Gross profit

Op expenses

Op income

Non-Op income/ expenses

Taxes & Other

Net income

‪‪−1.20 M‬‬

‪‪−800.00 K‬‬

‪‪−400.00 K‬‬

‪0.00‬

‪‪400.00 K‬‬

Revenue

COGS

Gross profit

Expenses & adjustments

Net income

‪‪−1.20 M‬‬

‪‪−800.00 K‬‬

‪‪−400.00 K‬‬

‪0.00‬

‪‪400.00 K‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business

Period: 2023

Noninvasive Biological Response-activating Devices

By country

Period: 2023

United States

Europe

Australia

Israel

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue

Q3 '20

Q4 '20

‪0.00‬

‪‪40.00 K‬‬

‪‪80.00 K‬‬

‪‪120.00 K‬‬

‪‪160.00 K‬‬

Actual

Earnings

Next:May 20, 2025

Q3 '20

Q4 '20

‪−2.00‬

‪−1.50‬

‪−1.00‬

‪−0.50‬

‪0.00‬

Actual

Dividends

Dividend yield, history and sustainability

NAOV does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−1.30 M‬‬

‪0.00‬

‪‪1.30 M‬‬

‪‪2.60 M‬‬

‪‪3.90 M‬‬

Debt

Free cash flow

Cash & equivalents

Financial position analysis

Short term

Long term

‪0.00‬

‪‪1.10 M‬‬

‪‪2.20 M‬‬

‪‪3.30 M‬‬

‪‪4.40 M‬‬

Assets

Liabilities